Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation
Crossref DOI link: https://doi.org/10.1007/s11239-018-1773-4
Published Online: 2018-11-26
Published Print: 2019-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Castelli, Roberto
Gallipoli, Paolo
Schiavon, Riccardo
Teatini, Thomas
Deliliers, Giorgio Lambertenghi
Bergamaschini, Luigi
Text and Data Mining valid from 2018-11-26
Article History
First Online: 26 November 2018